Mérat P

No ORCID on file · 3 papers in corpus · active 1987-1988

Study types

  • article 3

Condition tags

  • endometriosis 2
article 1988
Escape from the down-regulation of the pituitary-ovarian axis following decreased infusion of luteinizing hormone-releasing hormone agonist
Fertility and Sterility ·doi:10.1016/s0015-0282(16)59887-2

In order to suppress the pituitary-ovarian axis for treatment of endometriosis, the luteinizing hormone-releasing hormone (LH-RH) agonist buserelin (Hoechst Canada Inc., Montreal, Quebec, Canada) was administered by continuous subcutaneous …

article 1988
Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase
Fertility and Sterility ·doi:10.1016/s0015-0282(16)59764-7

Six endometriosis patients were treated with continuous subcutaneous (SC) infusion of a luteinizing hormone-releasing hormone (LH-RH) agonist using an external osmotic minipump system. Serum estradiol (E2) was suppressed into the menopausal…

article 1987
LH-RH agonist treatment of endometriosis.
Contributions to gynecology and obstetrics